View Full Version : GSK Lupus Treatment Benlysta Reaches Europe After US Approval

05-20-2011, 11:11 AM
The first treatment developed for lupus in over 50 years has been reocommended for approval by the European Union this week. The watchdog, European Medicines Agency has backed the injectable drug that will cost Europeans $23,000 USD a year. Already approved in the United States in March 2011, the drug costs Americans $35,000 USD annually...

More... (http://www.medicalnewstoday.com/articles/226072.php)